Daegu, South Korea

Minsoo Song

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Pimedbio, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minsoo Song. Retrieved from https://idiyas.com/inventor/minsoo-song-9m40oi70

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Minsoo Song - Innovator in Pharmaceutical Applications

Introduction

Minsoo Song is an inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods and compositions for treating mental illness. Although he currently holds no granted patents, his work is noteworthy for its potential impact on healthcare.

Latest Patent Applications

Minsoo Song has submitted several patent applications, including:

1. **Carboxamide Derivative and Pharmaceutical Composition Comprising Same as Active Ingredient for Preventing or Treating Mental Illness** - This application discloses a carboxamide derivative that serves as an active ingredient for preventing or treating mental illness. The derivative is highly effective as a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine, making it a promising candidate for mental health treatments.

2. **Novel Method for Preparing Inotodiol** - This application relates to a novel method for preparing inotodiol, which differs from existing methods and offers a high yield. This innovation can be effectively utilized for the preparation and mass production of inotodiol.

Conclusion

Minsoo Song's innovative approaches in pharmaceutical applications highlight his potential as a valuable contributor to the field. His latest patent applications reflect a commitment to advancing treatments for mental illness and improving pharmaceutical production methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…